Combined Technique for Internal Carotid Artery Terminus or Middle Cerebral Artery Occlusions in the ASTER2 Trial.

endovascular procedures humans ischemic stroke middle cerebral artery retrospective studies

Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
21 Dec 2023
Historique:
medline: 21 12 2023
pubmed: 21 12 2023
entrez: 21 12 2023
Statut: aheadofprint

Résumé

The aim of this study was to report the results of a subgroup analysis of the ASTER2 trial (Effect of Thrombectomy With Combined Contact Aspiration and Stent Retriever vs Stent Retriever Alone on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion) comparing the safety and efficacy of the combined technique (CoT) and stent retriever as a first-line approach in internal carotid artery (ICA) terminus±M1-middle cerebral artery (M1-MCA) and isolated M1-MCA occlusions. Patients enrolled in the ASTER2 trial with ICA terminus±M1-MCA and isolated M1-MCA occlusions were included in this subgroup analysis. The effect of first-line CoT versus stent retriever according to the occlusion site was assessed on angiographic (first-pass effect, expanded Treatment in Cerebral Infarction score ≥2b50, and expanded Treatment in Cerebral Infarction score ≥2c grades at the end of the first-line strategy and at the end of the procedure) and clinicoradiological outcomes (24-hour National Institutes of Health Stroke Scale, ECASS-III (European Cooperative Acute Stroke Study) grades, and 3-month modified Rankin Scale). Three hundred sixty-two patients were included in the postsubgroup analysis according to the occlusion site: 299 were treated for isolated M1-MCA occlusion (150 with first-line CoT) and 63 were treated for ICA terminus±M1-MCA occlusion (30 with first-line CoT). Expanded Treatment in Cerebral Infarction score ≥2b50 (odds ratio, 11.83 [95% CI, 2.32-60.12]) and expanded Treatment in Cerebral Infarction score ≥2c (odds ratio, 4.09 [95% CI, 1.39-11.94]) were significantly higher in first-line CoT compared with first-line stent retriever in patients with ICA terminus±M1-MCA occlusion but not in patients with isolated M1-MCA. First-line CoT was associated with higher reperfusion grades in patients with ICA terminus±M1-MCA at the end of the procedure. URL: https://www.clinicaltrials.gov; Unique identifier: NCT03290885.

Sections du résumé

BACKGROUND UNASSIGNED
The aim of this study was to report the results of a subgroup analysis of the ASTER2 trial (Effect of Thrombectomy With Combined Contact Aspiration and Stent Retriever vs Stent Retriever Alone on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion) comparing the safety and efficacy of the combined technique (CoT) and stent retriever as a first-line approach in internal carotid artery (ICA) terminus±M1-middle cerebral artery (M1-MCA) and isolated M1-MCA occlusions.
METHODS UNASSIGNED
Patients enrolled in the ASTER2 trial with ICA terminus±M1-MCA and isolated M1-MCA occlusions were included in this subgroup analysis. The effect of first-line CoT versus stent retriever according to the occlusion site was assessed on angiographic (first-pass effect, expanded Treatment in Cerebral Infarction score ≥2b50, and expanded Treatment in Cerebral Infarction score ≥2c grades at the end of the first-line strategy and at the end of the procedure) and clinicoradiological outcomes (24-hour National Institutes of Health Stroke Scale, ECASS-III (European Cooperative Acute Stroke Study) grades, and 3-month modified Rankin Scale).
RESULTS UNASSIGNED
Three hundred sixty-two patients were included in the postsubgroup analysis according to the occlusion site: 299 were treated for isolated M1-MCA occlusion (150 with first-line CoT) and 63 were treated for ICA terminus±M1-MCA occlusion (30 with first-line CoT). Expanded Treatment in Cerebral Infarction score ≥2b50 (odds ratio, 11.83 [95% CI, 2.32-60.12]) and expanded Treatment in Cerebral Infarction score ≥2c (odds ratio, 4.09 [95% CI, 1.39-11.94]) were significantly higher in first-line CoT compared with first-line stent retriever in patients with ICA terminus±M1-MCA occlusion but not in patients with isolated M1-MCA.
CONCLUSIONS UNASSIGNED
First-line CoT was associated with higher reperfusion grades in patients with ICA terminus±M1-MCA at the end of the procedure.
REGISTRATION UNASSIGNED
URL: https://www.clinicaltrials.gov; Unique identifier: NCT03290885.

Identifiants

pubmed: 38126181
doi: 10.1161/STROKEAHA.123.045227
doi:

Banques de données

ClinicalTrials.gov
['NCT03290885']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Raphael Blanc (R)
Hocine Redjem (H)
Gabriele Ciccio (G)
Stanislas Smajda (S)
Mikael Mazighi (M)
Robert Fahed (R)
Georges Rodesch (G)
Oguzhan Coskun (O)
Federico Di Maria (F)
Frédéric Bourdain (F)
Jean Pierre Decroix (JP)
Adrien Wang (A)
Maya Tchikviladze (M)
Serge Evrard (S)
Francis Turjman (F)
Paul Emile Labeyrie (PE)
Roberto Riva (R)
Charbel Mounayer (C)
Alain Bonafé (A)
Omer Eker (O)
Grégory Gascou (G)
Serge Bracard (S)
Romain Tonnelet (R)
Anne Laure Derelle (AL)
René Anxionnat (R)
Hubert Desal (H)
B Daumas-Duport (B)
Jérome Berge (J)
Lynda Djemmane (L)
Alain Duhamel (A)

Auteurs

Alessandro Sgreccia (A)

Diagnostic and Interventional Neuroradiology, Foch Hospital, Suresnes, France (A.S., B.L., A.C.).

Jean-Philippe Desilles (JP)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris, France (J.-P.D., M.P.).

Vincent Costalat (V)

Department of Neuroradiology, Hôpital Gui de Chauliac, Montpellier University Medical Center, France (V.C., C.D.).

Cyril Dargazanli (C)

Department of Neuroradiology, Hôpital Gui de Chauliac, Montpellier University Medical Center, France (V.C., C.D.).

Romain Bourcier (R)

Department of Diagnostic and Interventional Neuroradiology, University Hospital of Nantes, France (R.B., G.T.).

Guillaume Tessier (G)

Department of Diagnostic and Interventional Neuroradiology, University Hospital of Nantes, France (R.B., G.T.).

Aymeric Rouchaud (A)

Interventional Neuroradiology Department, Centre Hospitalier Universitaire Limoges, France (A.R., S.S.).

Suzana Saleme (S)

Interventional Neuroradiology Department, Centre Hospitalier Universitaire Limoges, France (A.R., S.S.).

Laurent Spelle (L)

Interventional Neuroradiology Department, Kremlin Bicêtre Hospital, France (L.S., J.C.).

Jildaz Caroff (J)

Interventional Neuroradiology Department, Kremlin Bicêtre Hospital, France (L.S., J.C.).

Gaultier Marnat (G)

Interventional Neuroradiology Department, Centre Hospitalier Régional Universitaire Bordeaux, France (G.M., X.B.).

Xavier Barreau (X)

Interventional Neuroradiology Department, Centre Hospitalier Régional Universitaire Bordeaux, France (G.M., X.B.).

Frédéric Clarençon (F)

Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France (F.C., E.S.).

Eimad Shotar (E)

Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France (F.C., E.S.).

François Eugene (F)

Department of Neuroradiology, Centre Hospitalier Universitaire de Rennes, France (F.E.).

Emmanuel Houdart (E)

Department of Neuroradiology, Lariboisière Hospital, Paris, France (E.H.).

Benjamin Gory (B)

Department of Neuroradiology, Centre Hospitalier Universitaire de Rennes, France (B.G., F.Z.).

François Zhu (F)

Department of Neuroradiology, Centre Hospitalier Universitaire de Rennes, France (B.G., F.Z.).

Julien Labreuche (J)

Department of Biostatistics, Centre Hospitalier Universitaire Lille, Equipe d'accueil 2694 Santé Publique: Epidémiologie et Qualité des Soins, University Lille, France (J.L.).

Michel Piotin (M)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris, France (J.-P.D., M.P.).

Bertrand Lapergue (B)

Diagnostic and Interventional Neuroradiology, Foch Hospital, Suresnes, France (A.S., B.L., A.C.).

Arturo Consoli (A)

Diagnostic and Interventional Neuroradiology, Foch Hospital, Suresnes, France (A.S., B.L., A.C.).

Classifications MeSH